Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer (rapid review of TA1108) [ID6685]

  • In development
  • GID-TA12074
  • Expected publication date: TBC

Status:
In progress
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

MA review of TA1108

Process:
STA Standard
ID number:
6685

Timeline

Key events during the development of the guidance:

Date Update
23 April 2026 In progress. MA review of TA1108
20 April 2026 Awaiting development. Status change linked to topic prioritisation decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual